Your Article Summary
Sun JS et al. - Careful combined assessment of the FDG-PET maximal SUV and CT findings have the potential to differentiate an adenocarcinoma with BAC from other NSCLC subtypes, such as a pure BAC. These findings might be useful for imaging interpretations and will help initial planning of NSCLC management.
Today in Diagnostic/Lung Function...keeping you current
Receive free subspecialty "5-minute updates" via email
Pulmonary function testing in young children
Paediatric Respiratory Reviews, 11/04/09
Novel Influenza A(H1N1): Clinical Presentation, Diagnosis, and Management
Pediatric Emergency Care, 11/16/09
Newer diagnostic techniques for tuberculosis
Respiratory Medicine CME, 11/24/09
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer
Journal of Clinical Oncology, 11/05/09
Tumor necrosis factor inhibitors and lung disease: A paradox of efficacy and risk
Seminars in Arthritis and Rheumatism, 11/20/09
Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial
Lung Cancer, 11/03/09

See Latest Articles